BGA
FBIO icon

Belmont Global Advisors’s Fortress Biotech FBIO Stock Holding History

Belmont Global Advisors’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$297K Buy
+6,667
New +$284K 0.28% 50

Other funds holding FBIO

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Belmont Global Advisors's FBIO Position: Q3 2016 in Review

Belmont Global Advisors reduced its Fortress Biotech (FBIO) stake by 0.91% in Q3 2016, selling an estimated $14.2K and leaving 36,333 shares worth $1.62M. The position accounts for 1.53% of the portfolio, ranked #8.

Belmont Global Advisors first reported a position in FBIO in Q3 2014 and has held it in 8 quarters since. The position peaked at $2.63M in Q2 2015. 50 funds tracked by Wall St. Rank hold FBIO as of Q3 2016.

  • Belmont Global Advisors held 36,333 shares of Fortress Biotech worth $1.62M as of Q3 2016.
  • Belmont Global Advisors sold 334 Fortress Biotech shares in Q3 2016, an estimated $14.2K.
  • Fortress Biotech made up 1.53% of Belmont Global Advisors's portfolio in Q3 2016, its #8 holding.
  • Belmont Global Advisors first reported a position in Fortress Biotech in Q3 2014 and has held it in 8 quarters since.
  • Belmont Global Advisors's Fortress Biotech position peaked at $2.63M in Q2 2015.
  • 50 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2016.

Based on Belmont Global Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.